| 标题 |
Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48-ADC) combined immunotherapy in patients with muscle-invasive bladder cancer: A multi-center real-world study |
| 网址 | |
| DOI | |
| 其它 |
期刊:iMeta 作者:Hu J; Yan L; Liu J; Chen M; Liu P; et al 出版日期:2025/04/14 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)